Epigenetic mechanisms in Alzheimer's disease

Current Medicinal Chemistry

Volumn 18, Issue 12, 2011, Pages 1751-1756

  Daniilidou, M ^a   Koutroumani, M ^a   Tsolaki, M ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Alzheimer's disease; DNA methylation; Epigenetics; Histone acetylation

Indexed keywords

4 PHENYLBUTYRIC ACID; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DNA METHYLTRANSFERASE 1; PRESENILIN 1; PRESENILIN 2; S ADENOSYLMETHIONINE; VALPROIC ACID;

ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; DNA METHYLATION; EPIGENETICS; GENETIC TRANSCRIPTION; HISTONE ACETYLATION; HISTONE METHYLATION; HISTONE MODIFICATION; HISTONE PHOSPHORYLATION; HUMAN; NONHUMAN;

AGE OF ONSET; AGED; ALZHEIMER DISEASE; EPIGENESIS, GENETIC; HUMANS; TRANSCRIPTION, GENETIC;

EID: 79955696887     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986711795496872     Document Type: Article

References (75)

1. Finder, V.H. Alzheimer's Disease: A General Introduction and Pathomechanism. J Alzheimers Dis, 2010 Sep 21.
2. Qiu, C.; De Ronchi, D.; Fratiglioni, L. The epidemiology of the dementias: an update. Curr Opin Psychiatry, 2007, 20(4), 380-385. (Pubitemid 46889665)
3. Hardy, J.; Selkoe, D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science, 2002, 297(5580), 353-356. (Pubitemid 34790756)
4. St George-Hyslop, P.H.; Petit, A. Molecular biology and genetics of Alzheimer's disease. C R Biol., 2005, 328(2), 119-130. (Pubitemid 40247057)
5. Haass, C.; Koo, E.H.; Mellon, A.; Hung, A.Y.; Selkoe, D.J. Targeting of cell-surface beta-amyloid precursor protein to lysosomes: Alternative processing into amyloid-bearing fragments. Nature, 1992, 357, 500-503.
6. Borchelt, D.R.; Thinakaran, G.; Eckman, C.B.; Lee, M.K.; Davenport, F.; Ratovitsky, T.; Prada, C.M.; Kim, G.; Seekins, S.; Yager, D.; Slunt, H.H.; Wang, R.; Seeger, M.; Levey, A.I.; Gandy, S.E.; Copeland, N.G.; Jenkins, N.A.; Price, D.L.; Younkin, S.G.; Sisodia, S.S. Familial Alzheimer's diseaselinked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron, 1996, 17, 1005-1013. (Pubitemid 26424026)
7. Pratico, D. Oxidative stress hypothesis in Alzheimer's disease: a reappraisal. Trends Pharmacol. Sci.,2008, 29, 609-615.
8. Santos R.X.; Correia S.C.; Wang X.; Perry G.; Smith M.A.; Moreira P.I.; Zhu X. A synergistic dysfunction of mitochondrial fission/fusion dynamics and mitophagy in Alzheimer's disease. J Alzheimers Dis., 2010;20 Suppl 2:S401-12.
9. Vaya, J.; Schipper, H.M. Oxysterols, cholesterol homeostasis, and Alzheimer disease. J Neurochem., 2007, 102(6), 1727-1737. (Pubitemid 47329280)
10. Goate, A.; Chartier-Harlin, M.C.; Mullan, M.; Brown, J.; Crawford, F.; Fidani, L.; Giuffra, L.; Haynes, A.; Irving, N.; James, L. et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature, 1991, 349(6311), 704-706. (Pubitemid 21912142)
11. Jarrett, J.T.; Lansbury, P.T. Jr. Seeding "one-dimensional crystallization" of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? Cell, 1993, 73, 1055-1058. (Pubitemid 23180480)
12. Alzheimer Disease and Frontotemporal Dementia Mutation Database. Mutations in APP. http://www.molgen.ua.ac.be/ADMutations/default.cfm? MT=1&ML=1&Page=MutByQuery&Query=tblContexts.GeneSymbol%20I n%20%28%27APP%27%29&Selection=Gene%20In%20%28APP%29 (Accessed October 12, 2010).
13. Kimberly, W.T.; LaVoie, M.J.; Ostaszewski, B.L.; Ye, W.; Wolfe, M.S.; Selkoe, D.J. Gamma-secretase is a membrane protein complex comprised of presenilin, nicastrin, Aph-1, and Pen-2. Proc Natl Acad Sci USA, 2003, 100, 6382-6387. (Pubitemid 36666590)
14. Doan, A.; Thinakaran, G.; Borchelt, D.R.; Slunt, H.H.; Ratovitsky, T.; Podlisny, M.; and others. Protein topology of presenilin 1. Neuron, 1996, 17(5), 1023-1030. (Pubitemid 26424028)
15. Dewji, N.N.; Singer, S.J. The seven-transmembrane spanning topography of the Alzheimer disease-related presenilin proteins in the plasma membranes of cultured cells. Proc Natl Acad Sci U S A, 1997, 94(25), 14025-14030.
16. Alzheimer Disease and Frontotemporal Dementia Mutation Database. Mutations in PSEN1. http://www.molgen.ua.ac.be/ADMutations/default. cfm?MT=1&ML=1&Page=MutByQuery&Query=tblContexts.GeneSy mbol%20In%20%28%27PSEN1%27%29&Selection=Gene%20In%20%28P SEN1%29 (Accessed October 12, 2010).
17. Alzheimer Disease and Frontotemporal Dementia Mutation Database. Mutations in PSEN2. http://www.molgen.ua.ac.be/ADMutations/default.cfm? MT=1&ML=1&Page=MutByQuery&Query=tblContexts.GeneSymbol%20I n%20%28%27PSEN2%27%29&Selection=Gene%20In%20%28PSEN2%29 (Accessed October 12, 2010).
18. Rogaeva, E.I.; Sherrington, R.; Rogaeva, E.A.; Levesque, G.; Ikeda, M.; Liang, Y. et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature, 1995, 376, 775-778.
19. Levy-Lahad, E.; Wasco, W.; Poorkaj, P.; Romano, D.M.; Oshima, J.; Pettingell, W.H.; Yu, C.E.; Jondro, P.D.; Schmidt, S.D.; Wang, K. et al.Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science, 1995, 269(5226), 973-977.
20. De Strooper, B.; Saftig, P.; Craessaerts, K.; Vanderstichele, H.; Guhde, G.; Annaert, W.; Von Figura, K.; Van Leuven, F. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature, 1998, 391, 387-390. (Pubitemid 28093512)
21. Saunders, A.M.; Strittmatter, W.J.; Schmechel, D.; George-Hyslop, P.H.; Pericak-Vance, M.A.; Joo, S.H.; Rosi, B.L.; Gusella, J.F.; Crapper- MacLachlan, D.R.; Alberts, M.J. et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology, 1993, 43(8), 1467-1472. (Pubitemid 23230526)
22. Farrer, L.A.; Cupples, L.A.; Haines, J.L.; Hyman, B.; Kukull, W.A.; Mayeux, R.; Myers, R.H.; Pericak-Vance, M.A.; Risch, N.; van Duijn, C.M. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA, 1997, 278(16), 1349-1356. (Pubitemid 27449696)
23. Ertekin-Taner, N. Genetics of Alzheimer disease in the pre- and post-GWAS era. Alzheimers Res Ther., 2010, 2(1), 3.
24. Lambert, J.C.; Heath, S.; Even, G.; Campion, D.; Sleegers, K.; Hiltunen, M.; Combarros, O.; Zelenika, D.; Bullido, M.J.; Tavernier, B.; Letenneur, L.; Bettens, K.; Berr, C.; Pasquier, F.; Fiévet, N.; Barberger-Gateau, P.; Engelborghs, S.; De Deyn, P.; Mateo, I.; Franck, A.; Helisalmi, S.; Porcellini, E.; Hanon, O.; European Alzheimer's Disease Initiative Investigators; de Pancorbo, M.M.; Lendon, C.; Dufouil, C.; Jaillard, C.; Leveillard, T.; Alvarez, V.; Bosco, P.; Mancuso, M.; Panza, F.; Nacmias, B.; Bossù, P.; Piccardi, P.; Annoni, G.; Seripa, D.; Galimberti, D.; Hannequin, D.; Licastro, F.; Soininen, H.; Ritchie, K.; Blanché, H.; Dartigues, J.F.; Tzourio, C.; Gut, I.; Van Broeckhoven, C.; Alpérovitch, A.; Lathrop, M.; Amouyel, P. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet., 2009, 41(10), 1094-1099.
25. Harold, D.; Abraham, R.; Hollingworth, P.; Sims, R.; Gerrish, A.; Hamshere, M.L.; Pahwa, J.S.; Moskvina, V.; Dowzell, K.; Williams, A.; Jones, N.; Thomas, C.; Stretton, A.; Morgan, A.R.; Lovestone, S.; Powell, J.; Proitsi, P.; Lupton, M.K.; Brayne, C.; Rubinsztein, D.C.; Gill, M.; Lawlor, B.; Lynch, A.; Morgan, K.; Brown, K.S.; Passmore, P.A.; Craig, D.; McGuinness, B.; Todd, S.; Holmes, C.; Mann, D.; Smith, A.D.; Love, S.; Kehoe, P.G.; Hardy, J.; Mead, S.; Fox, N.; Rossor, M.; Collinge, J.; Maier, W.; Jessen, F.; Schürmann, B.; van den Bussche, H.; Heuser, I.; Kornhuber, J.; Wiltfang, J.; Dichgans, M.; Frölich, L.; Hampel, H.; Hüll, M.; Rujescu, D.; Goate, A.M.; Kauwe, J.S.; Cruchaga, C.; Nowotny, P.; Morris, J.C.; Mayo, K.; Sleegers, K.; Bettens, K.; Engelborghs, S.; De Deyn, P.P.; Van Broeckhoven, C.; Livingston, G.; Bass, N.J.; Gurling, H.; McQuillin, A.; Gwilliam, R.; Deloukas, P.; Al-Chalabi, A.; Shaw, C.E.; Tsolaki, M.; Singleton, A.B.; Guerreiro, R.; Mühleisen, T.W.; Nöthen, M.M.; Moebus, S.; Jöckel, K.H.; Klopp, N.; Wichmann, H.E.; Carrasquillo, M.M.; Pankratz, V.S.; Younkin, S.G.; Holmans, P.A.; O'Donovan, M.; Owen, M.J.; Williams, J. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet., 2009, 41(10), 1088-1093.
26. Shcherbatykh, I.; Carpenter, D.O. The role of metals in the etiology of Alzheimer's disease. J Alzheimers Dis., 2007, 11(2), 191-205. (Pubitemid 47010984)
27. Qiu, C.; Fratiglioni, L.; Karp, A.; Winblad, B.; Bellander, T. Occupational exposure to electromagnetic fields and risk of Alzheimer's disease. Epidemiology, 2004, 15(6), 687-694. (Pubitemid 40416884)
28. Kukull, W.A.; Higdon, R.; Bowen, J.D.; McCormick, W.C.; Teri, L.; Schellenberg, G.D.; van Belle, G.; Jolley, L.; Larson, E.B. Dementia and Alzheimer disease incidence: a prospective cohort study. Arch Neurol., 2002, 59(11), 1737-1746. (Pubitemid 35340484)
29. Rocchi, A.; Orsucci, D.; Tognoni, G.; Ceravolo, R., Siciliano, G. The role of vascular factors in late-onset sporadic Alzheimer's disease. Genetic and molecular aspects. Curr Alzheimer Res., 2009, 6(3), 224-237.
30. Bruce, D.G.; Harrington, N., Davis, W.A.; Davis, T.M.; Fremantle Diabetes Study. Dementia and its associations in type 2 diabetes mellitus: the Fremantle Diabetes Study. Diabetes Res Clin Pract., 2001, 53(3), 165-172. (Pubitemid 32727734)
31. Magnoni, S.; Brody, D.L. New perspectives on amyloid-beta dynamics after acute brain injury: moving between experimental approaches and studies in the human brain. Arch Neurol., 2010, 67(9), 1068-1073.
32. Luchsinger, J.A.; Mayeux, R. Dietary factors and Alzheimer's disease. Lancet Neurol., 2004, 3(10), 579-587. (Pubitemid 39221925)
33. Suzuki, M.M; Bird, A. DNA methylation landscapes: provocative insights from epigenomics. Nat Rev Genet., 2008, 9(6), 465-476. (Pubitemid 351693975)
34. Jones, P.A.; Takai, D. The role of DNA methylation in mammalian epigenetics. Science, 2001, 293(5532):1068-1070. (Pubitemid 32758075)
35. Dhasarathy, A.; Wade, P.A. The MBD protein family-reading an epigenetic mark? Mutat Res., 2008, 647(1-2), 39-43.
36. Bestor, T.H. The DNA methyltransferases of mammals. Hum Mol Genet., 2000, 9(16), 2395-2402.
37. Kouzarides, T. Chromatin modifications and their function. Cell, 2007, 128(4), 693-705. (Pubitemid 46273577)
38. Felsenfeld, G.; Groudine, M. Controlling the double helix. Nature, 2003, 421(6921), 448-453. (Pubitemid 36157954)
39. Yang, X.J.; Seto, E. HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention. Oncogene, 2007, 26(37), 5310-5318. (Pubitemid 47255917)
40. Abel, T.; Zukin, R.S. Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders. Curr Opin Pharmacol, 2008, 8(1), 57-64.
41. Macdonald, N.; Welburn, J.P.; Noble, M.E.; Nguyen, A.; Yaffe, M.B.; Clynes, D.; Moggs, J.G.; Orphanides, G.; Thomson, S.; Edmunds, J.W.; Clayton, A.L.; Endicott, J.A.; Mahadevan, L.C. Molecular basis for the recognition of phosphorylated and phosphoacetylated histone h3 by 14-3-3. Mol Cell, 2005, 20(2), 199-211. (Pubitemid 41484166)
42. Nowak, S.J.; Corces, V.G. Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation. Trends Genet, 2004, 20(4), 214-220. (Pubitemid 38369193)
43. Wei, Y.; Yu, L.; Bowen, J.; Gorovsky, M.A.; Allis, C.D. Phosphorylation of histone H3 is required for proper chromosome condensation and segregation. Cell, 1999, 97(1), 99-109. (Pubitemid 29165893)
44. Volpe, T.; Kidner, C.; Hall, I.; Teng, G.; Grewal, S.; Martienssen, R. Heterochromatic silencing and histone H3 lysine 9 methylation are regulated by RNA interference. Science, 2002, 297, 1833-1837. (Pubitemid 35024336)
45. Zilberman, D.; Cao, X.; Jacobsen, S.E. ARGONAUTE4 control of locus specific siRNA accumulation and DNA and histone methylation. Science, 2003, 299, 716-719. (Pubitemid 36159488)
46. Salbaum, J.M.; Weidemann, A.; Lemaire, H.G.; Masters, C.L.; Beyreuther, K. The promoter of Alzheimer's disease amyloid A4 precursor gene. EMBO J., 1988, 7(9), 2807-2813.
47. Tohgi, H.; Utsugisawa, K.; Nagane, Y.; Yoshimura, M.; Genda, Y.; Ukitsu, M. Reduction with age in methylcytosine in the promoter region -224 approximately -101 of the amyloid precursor protein gene in autopsy human cortex. Brain Res Mol Brain Res, 1999, 70(2), 288-292. (Pubitemid 29317643)
48. Mulder, C.; Schoonenboom, N.S.; Jansen, E.E.; Verhoeven, N.M.; van Kamp, G.J.; Jakobs, C.; Scheltens, P. The transmethylation cycle in the brain of Alzheimer patients. Neurosci Lett, 2005, 386(2), 69-71. (Pubitemid 41058933)
49. Obeid, R.; Herrmann, W. Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett, 2006, 580(13), 2994-3005. (Pubitemid 43744523)
50. Wang, S.C.; Oelze, B.; Schumacher, A. Age-specific epigenetic drift in lateonset Alzheimer's disease. PLoS One, 2008, 3(7), e2698.
51. Mastroeni, D.; McKee, A.; Grover, A.; Rogers, J.; Coleman, P.D. Epigenetic differences in cortical neurons from a pair of monozygotic twins discordant for Alzheimer's disease. PLoS One, 2009, 4(8), e6617.
52. Mastroeni, D.; Grover, A.; Delvaux, E.; Whiteside, C.; Coleman, P.D.; Rogers, J. Epigenetic changes in Alzheimer's disease: Decrements in DNA methylation. Neurobiol Aging, 2008.
53. Scarpa, S.; Fuso, A.; D'Anselmi, F.; Cavallaro, R.A. Presenilin 1 gene silencing by S-adenosylmethionine: a treatment for Alzheimer disease? FEBS Lett., 2003, 541(1-3), 145-148. (Pubitemid 36428933)
54. Silva, P.N.; Gigek, C.O.; Leal, M.F.; Bertolucci, P.H.; de Labio, R.W.; Payão, S.L.; Smith, M.de A. Promoter methylation analysis of SIRT3, SMARCA5, HTERT and CDH1 genes in aging and Alzheimer's disease. J Alzheimers Dis., 2008, 13(2), 173-176. (Pubitemid 352038520)
55. Takiguchi, M.; Achanzar, W.E.; Qu, W.; Li, G.; Waalkes, M.P. Effects of cadmium on DNA-(Cytosine-5) methyltransferase activity and DNA methylation status during cadmium-induced cellular transformation. Exp Cell Res., 2003, 286(2), 355-365. (Pubitemid 36566447)
56. Basha, M.R.; Wei, W.; Bakheet, S.A.; Benitez, N.; Siddiqi, H.K.; Ge, Y.W.; Lahiri, D.K.; Zawia, N.H. The fetal basis of amyloidogenesis: exposure to lead and latent overexpression of amyloid precursor protein and betaamyloid in the aging brain. J Neurosci., 2005, 25(4), 823-829. (Pubitemid 40170996)
57. Wu, J.; Basha, M.R.; Brock, B.; Cox, D.P.; Cardozo-Pelaez, F.; McPherson, C.A.; Harry, J.; Rice, D.C.; Maloney, B.; Chen, D.; Lahiri, D.K.; Zawia, N.H. Alzheimer's disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD. J Neurosci, 2008, 28(1), 3-9.
58. Wu, J.; Basha, M.R.; Zawia, N.H. The environment, epigenetics and amyloidogenesis. J Mol Neurosci., 2008, 34(1), 1-7. (Pubitemid 351378089)
59. Zheng, W.; Xin, N.; Chi, Z.H.; Zhao, B.L.; Zhang, J.; Li, J.Y.; Wang, Z.Y. Divalent metal transporter 1 is involved in amyloid precursor protein processing and Abeta generation. FASEB J., 2009, 23(12), 4207-4217.
60. Chen, K.L.; Wang, S.S.; Yang, Y.Y.; Yuan, R.Y.; Chen, R.M.; Hu, C.J. The epigenetic effects of amyloid-beta(1-40) on global DNA and neprilysin genes in murine cerebral endothelial cells. Biochem Biophys Res Commun, 2009, 378(1), 57-61.
61. Marr, R.A.; Rockenstein, E.; Mukherjee, A.; Kindy, M.S.; Hersh, L.B.; Gage, F.H.; Verma, I.M.; Masliah, E. Neprilysin gene transfer reduces human amyloid pathology in transgenic mice. J Neurosci, 2003, 23(6), 1992-1996. (Pubitemid 36368884)
62. Russo, R.; Borghi, R.; Markesbery, W.; Tabaton, M.; Piccini, A. Neprylisin decreases uniformly in Alzheimer's disease and in normal aging. FEBS Lett, 2005, 579(27), 6027-6030. (Pubitemid 41546241)
63. Siegmund, K.D.; Connor, C.M.; Campan, M.; Long, T.I.; Weisenberger, D.J.; Biniszkiewicz, D.; Jaenisch, R.; Laird, P.W.; Akbarian, S. DNA methylation in the human cerebral cortex is dynamically regulated throughout the lifespan and involves differentiated neurons. PLoS One, 2007, 2(9), e895.
64. Akamatsu, M.; Aota, S.; Suwa, A.; Ueda, K.; Amachi, T.; Yamada, K.M.; Akiyama, S.K.; Kioka, N. Vinexin forms a signaling complex with Sos and modulates epidermal growth factor-induced c-Jun N-terminal kinase/ stressactivated protein kinase activities. J Biol Chem, 1999, 274(50), 35933-35937. (Pubitemid 129512901)
65. Peleg, S.; Sananbenesi, F.; Zovoilis, A.; Burkhardt, S.; Bahari-Javan ,S.; Agis-Balboa, R.C.; Cota, P.; Wittnam, J.L.; Gogol-Doering, A.; Opitz, L.; Salinas-Riester, G.; Dettenhofer, M.; Kang, H.; Farinelli, L.; Chen, W.; Fischer, A. Altered histone acetylation is associated with age-dependent memory impairment in mice. Science, 2010, 328(5979), 753-756.
66. Huysseune, S.; Kienlen-Campard, P.; Hébert, S.; Tasiaux, B.; Leroy, K.; Devuyst, O.; Brion, J.P.; De Strooper, B.; Octave, J.N. Epigenetic control of aquaporin 1 expression by the amyloid precursor protein. FASEB J, 2009, 23(12), 4158-4167.
67. Goodman, R.H.; Smolik, S. CBP/p300 in cell growth, transformation, and development. Genes Dev, 2000, 14(13), 1553-1577. (Pubitemid 30460905)
68. Korzus, E.; Rosenfeld, M.G.; Mayford, M. CBP histone acetyltransferase activity is a critical component of memory consolidation. Neuron, 2004, 42(6), 961-972. (Pubitemid 38798234)
69. Zhang, M.; Poplawski, M.; Yen, K.; Cheng, H.; Bloss, E.; Zhu, X.; Patel, H.; Mobbs, C.V. Role of CBP and SATB-1 in aging, dietary restriction, and insulin- like signaling. PLoS Biol, 2009, 7(11), e1000245.
70. Smith, A.M.; Gibbons, H.M.; Dragunow, M. Valproic acid enhances microglial phagocytosis of amyloid-beta(1-42). Neuroscience, 2010, 169(1), 505-515.
71. Dragunow, M.; Greenwood, J.M.; Cameron, R.E.; Narayan, P.J.; O'Carroll, S.J.; Pearson, A.G.; Gibbons, H.M. Valproic acid induces caspase 3- mediated apoptosis in microglial cells. Neuroscience, 2006, 140(4), 1149-1156. (Pubitemid 43928264)
72. Chen, P.S.; Peng, G.S.; Li, G.; Yang, S.; Wu, X.; Wang, C.C.; Wilson, B.; Lu, R.B.; Gean, P.W.; Chuang, D.M.; Hong, J.S. Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes. Mol Psychiatry, 2006, 11(12), 1116-1125. (Pubitemid 44867481)
73. Herrmann, N.; Lanctôt, K.L.; Rothenburg, L.S.; Eryavec, G. A placebocontrolled trial of valproate for agitation and aggression in Alzheimer's disease. Dement Geriatr Cogn Disord., 2007, 23(2), 116-119. (Pubitemid 46105702)
74. Guan, J.S.; Haggarty, S.J.; Giacometti, E.; Dannenberg, J.H.; Joseph, N.; Gao, J.; Nieland, T.J.; Zhou, Y.; Wang, X.; Mazitschek, R.; Bradner, J.E.; DePinho, R.A.; Jaenisch, R.; Tsai, L.H. HDAC2 negatively regulates memory formation and synaptic plasticity. Nature, 2009, 459(7243), 55-60.
75. Fischer, A.; Sananbenesi, F.; Wang, X.; Dobbin, M.; Tsai, L.H. Recovery of learning and memory is associated with chromatin remodelling. Nature, 2007, 447(7141), 178-182. (Pubitemid 46763080)